HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate's UK Whitening Claims Shine On Clinical Data, Consumer Perception

This article was originally published in The Pink Sheet

Executive Summary

Colgate substantiates claims in TV and online ads for Colgate Max White Expert White toothpaste and Max White toothbrush with clinical and consumer perception studies showing the products could make teeth “3 shades whiter” in five days.

You may also be interested in...



Colgate Slams Industry Self-Regulation Review But Agrees To Pull Optic White Stain Removal Claim

BBB National Programs’ appeals panel decision “includes factual and substantive inaccuracies, is not in accordance with NARB procedures, and misstates Colgate’s positions and arguments,” Colgate says. Panel upheld findings agreeing with P&G’s challenge of “removes 10 years of yellow stains” claim.

Colgate Sensitivity Toothpaste Misses Instant Repair Mark In UK Ad Review

Colgate Sensitive Repair and Prevent toothpaste can relieve tooth sensitivity but cannot regenerate enamel that had worn away or restore receding gums, as suggested in a TV ad for the product, says UK Advertising Standards Authority.

FTC Review Of Colgate Optic White Claims Stalls Class Action Complaint

A Colgate Optic White whitening claims class action complaint is stayed pending an FTC decision on the claims, says a federal judge in response to Colgate’s motion to dismiss or stay the litigation. The judge denied the firm’s motion to dismiss on the grounds the state suit is pre-empted by FDA regulations.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS122879

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel